L
Linda Kalilani-Phiri
Researcher at University of Malawi
Publications - 48
Citations - 1265
Linda Kalilani-Phiri is an academic researcher from University of Malawi. The author has contributed to research in topics: Malaria & Pregnancy. The author has an hindex of 18, co-authored 46 publications receiving 1052 citations. Previous affiliations of Linda Kalilani-Phiri include Liverpool School of Tropical Medicine.
Papers
More filters
Journal ArticleDOI
Contraceptive Knowledge, Beliefs and Attitudes in Rural Malawi: Misinformation, Misbeliefs and Misperceptions
TL;DR: Despite knowing about the different types of family planning methods, and awareness of their ready availability in health facilities, use of these methods is low because considerable misinformation still prevails regarding contraceptive methods' side effects.
Journal ArticleDOI
Investigating social consequences of unwanted pregnancy and unsafe abortion in Malawi: The role of stigma
Brooke A. Levandowski,Linda Kalilani-Phiri,Fannie Kachale,Paschal Awah,Godfrey Kangaude,Chisale Mhango +5 more
TL;DR: Premarital and extramarital pregnancies were highly stigmatized; stigma directly related to abortion was also found and community‐level discussions need to focus on reduction of stigma.
Journal ArticleDOI
Cohort Profile: The Malawi Longitudinal Study of Families and Health (MLSFH)
Hans-Peter Kohler,Susan Cotts Watkins,Jere R. Behrman,Philip Anglewicz,Iliana V. Kohler,Rebecca Thornton,James Mkandawire,Hastings Honde,Augustine Hawara,Ben Chilima,Chiwoza Bandawe,Victor Mwapasa,Peter Fleming,Linda Kalilani-Phiri +13 more
TL;DR: The Malawi Longitudinal Study of Families and Health (MLSFH) is one of very few long-standing, publicly available longitudinal cohort studies in a sub-Saharan African (SSA) context and provides a rare record of more than a decade of demographic, socioeconomic and health conditions in one of the world's poorest countries.
Journal ArticleDOI
Four artemisinin-based treatments in African pregnant women with malaria.
Divine Pekyi,Akua A. Ampromfi,Halidou Tinto,Maminata Traoré-Coulibaly,Marc Christian Tahita,Innocent Valea,Victor Mwapasa,Linda Kalilani-Phiri,Gertrude Kalanda,Mwayiwawo Madanitsa,Raffaella Ravinetto,Theonest K. Mutabingwa,Prosper Gbekor,Harry Tagbor,Gifty Antwi,Joris Menten,Maaike De Crop,Yves Claeys,Céline Schurmans,Chantal Van Overmeir,Kamala Thriemer,Jean-Pierre Van Geertruyden,Umberto D'Alessandro,Michael Nambozi,Modest Mulenga,Sebastian Hachizovu,Jean-Bertin Bukasa Kabuya,Joyce Mulenga +27 more
TL;DR: Artemether-lumefantrine was associated with the fewest adverse effects and with acceptable cure rates but provided the shortest posttreatment prophylaxis, whereas dihydroartemisinin-piperaquine had the best efficacy and an acceptable safety profile.
Journal ArticleDOI
The reliability of sexual partnership histories: implications for the measurement of partnership concurrency during surveys
Stéphane Helleringer,Hans-Peter Kohler,Linda Kalilani-Phiri,James Mkandawire,Benjamin Armbruster +4 more
TL;DR: Future empirical tests of the ‘concurrency hypothesis’ and interventions targeting concurrent partnerships should take reporting biases into account.